Atelvia (uh-TEL-vee-uh), a new delayed-release form of risedronate (Actonel), for postmenopausal osteoporosis
February 2011
You'll see Atelvia (uh-TEL-vee-uh), a new delayed-release form of risedronate (Actonel), for postmenopausal osteoporosis.
Atelvia will be promoted as more convenient because it's taken AFTER breakfast...instead of 30 to 60 minutes BEFORE breakfast like the other oral bisphosphonates.
Atelvia is designed to reduce interference with calcium, iron, and other cations that decrease bisphosphonate absorption.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote